GlassScriptPhysician profile
Farid Didari
NPI 1477944114
$5,630.91
in general payments reported to CMS, 2019-2025
23 companies · $978 in 2025
The $978 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $251 · 2021: $556 · 2022: $2,113 · 2023: $334 · 2024: $924 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,235.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,392.74 | 2022-2025 | |
| Stryker Corporation | $949.19 | 2020-2025 | Citrefix, Ortholoc 2 Lapifuse, Prophecy |
| Biotissue Holdings INC. | $697.29 | 2021-2025 | |
| Angiodynamics, INC. | $664.07 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Organogenesis INC. | $422.50 | 2021-2025 | Puraply Wound Matrix, Puraply |
| Integra Lifesciences Corporation | $304.08 | 2019-2022 | |
| Smith+Nephew, INC. | $291.13 | 2019-2025 | Stravix, Collagenase Santyl, Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $256.64 | 2019-2025 | Tapestry, A.L.P.S. |
| Bioventus LLC | $189.64 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Ossio INC | $156.19 | 2022-2023 | |
| Amgen INC. | $49.12 | 2025 | Krystexxa |
| Depuy Synthes Sales INC. | $42.39 | 2025 | Minibunion |
| Amniox Medical, INC. | $34.06 | 2020 | |
| Grt US Holding, INC. | $33.04 | 2021 | |
| Tactile Systems Technology INC | $23.82 | 2025 | Nimbl, Flexitouch Plus |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $22.75 | 2023 | Krystexxa |
| Kci USA, INC. | $18.14 | 2020 | |
| Cardiovascular Systems INC. | $17.52 | 2022 | |
| Bard Peripheral Vascular, INC. | $16.69 | 2022 | |
| Medline Industries LP | $15.29 | 2019 | |
| Osiris Therapeutics INC. | $13.36 | 2019 | |
| Arthrosurface Incorporated | $13.03 | 2019 | |
| Paragon 28, INC. | $8.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Didari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.